Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
M3 ( (JP:2413) ) has issued an update.
M3, Inc. announced the status of its share repurchase program, which involves buying back its own common shares as per the Companies Act of Japan and its Articles of Incorporation. The company repurchased 196,000 shares for approximately 437 million yen through open market purchases on the Tokyo Stock Exchange. This move is part of a broader plan approved by the Board of Directors to repurchase up to 20 million shares, with a maximum budget of 20 billion yen, potentially impacting the company’s market positioning and shareholder value.
The most recent analyst rating on (JP:2413) stock is a Hold with a Yen2396.00 price target. To see the full list of analyst forecasts on M3 stock, see the JP:2413 Stock Forecast page.
More about M3
M3, Inc. operates in the healthcare industry, focusing on providing medical-related services and products. The company is known for its digital health solutions and platforms that connect medical professionals and stakeholders, enhancing healthcare delivery and communication.
Average Trading Volume: 3,174,377
Technical Sentiment Signal: Hold
Current Market Cap: Yen1440.3B
See more data about 2413 stock on TipRanks’ Stock Analysis page.